Keratoconus is a disease of the eye that is mainly reported in young patients. Keratoconus causes progressive degeneration of the cornea and most effective treatment for this condition is basically getting a cornea transplant. This treatment method has only made it possible for treating a third of individuals affected and at the moment the request for corneas for this treatment has been reported to be three times the current supply anywhere in the world.
Symptoms associated with Keratoconus include progressive loss of vision as a result of myopia and astigmatism that sets in. Although the disease has a worldwide distribution, it has been reported in higher numbers in Islamic and Arabic countries. Cornea transplant is not only a tedious, specific and expensive process due to the shortage of corneas, but it is also risky owing to the fact that 18% of the interventions reject the cornea transplant during the three years after intervention. The percentage has also been reported to increase up to 100% in some cases.
Intracorneal transplantation has been a great success up to date. As a matter of fact, outcomes of study by VISSUM indicating a great improvement in the visual acuity and corneal stability in patients who had undergone the transplant. The incorporation of the new Intralase laser has made the interventions much safer, faster, reliable and comfortable for patients undergoing the transplantation.